Medication indicated for ocular hypertension
Patent 4303637 Issued on December 1, 1981. Estimated Expiration Date: 
April 4, 2000. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.
April 4, 2000. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.Patent References4-[2-(Isopropylamino)ethyl]pyrocatechol intraocular pressure lowering process Solid state ophthalmic medication Selective administration of drug with ocular therapeutic system Patent #: 4186184 InventorsAssigneeApplicationNo. 06/137456 filed on 04/04/1980US Classes:424/427, Ocular424/497Containing solid synthetic polymersExaminersPrimary: Rose, Shep K.Attorney, Agent or FirmInternational ClassA61K 9/00 (20060101)AbstractAn ocular therapeutic system is disclosed for dispensing a medicament to an ocular environment. The system comprises a beta-blocking drug in a polymer with the drug surrounded by the polymer. A method is disclosed for the management of ocular hypertension using the system. Also disclosed, is a composition comprising the drug and the polymer. | |
